X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (24) 24
humans (19) 19
animals (14) 14
female (11) 11
male (11) 11
mice (10) 10
cancer (8) 8
adult (6) 6
aged (6) 6
aged, 80 and over (6) 6
middle aged (6) 6
cells (5) 5
multidisciplinary sciences (5) 5
mutation (5) 5
oncology (5) 5
research (5) 5
gene expression (4) 4
neoplasms - pathology (4) 4
pharmacology & pharmacy (4) 4
proteins (4) 4
abridged index medicus (3) 3
antineoplastic agents - administration & dosage (3) 3
antineoplastic agents - adverse effects (3) 3
apoptosis (3) 3
biomarkers (3) 3
carcinoma (3) 3
cell line, tumor (3) 3
chemotactic factors - metabolism (3) 3
cytokines (3) 3
cytokines - metabolism (3) 3
disease models, animal (3) 3
gene expression regulation, neoplastic (3) 3
growth (3) 3
immunohistochemistry (3) 3
inhibitor of apoptosis proteins - antagonists & inhibitors (3) 3
interleukin-8 - metabolism (3) 3
ligands (3) 3
macaca fascicularis (3) 3
mutations (3) 3
neoplasms - drug therapy (3) 3
neoplasms - genetics (3) 3
rats (3) 3
receptors, cell surface - metabolism (3) 3
receptors, immunologic - metabolism (3) 3
receptors, interleukin-8a (3) 3
reverse transcriptase polymerase chain reaction (3) 3
species specificity (3) 3
treatment outcome (3) 3
tumors (3) 3
activation (2) 2
amino acid sequence (2) 2
analysis (2) 2
antibodies - therapeutic use (2) 2
antibodies, monoclonal, humanized - adverse effects (2) 2
antineoplastic agents - pharmacokinetics (2) 2
base sequence (2) 2
biochemistry & molecular biology (2) 2
biological sciences (2) 2
blood group antigens (2) 2
bone marrow transplantation (2) 2
brain - enzymology (2) 2
brain - pathology (2) 2
brain ischemia - pathology (2) 2
breast neoplasms - drug therapy (2) 2
cell biology (2) 2
cell line (2) 2
cells, cultured (2) 2
cerebral infarction - pathology (2) 2
chemokine ccl2 (2) 2
chemokine cxcl1 (2) 2
chemokines, cxc (2) 2
cloning, molecular (2) 2
cytokine family (2) 2
dogs (2) 2
dose-response relationship, drug (2) 2
drug evaluation, preclinical (2) 2
drug resistance, neoplasm (2) 2
endothelium, vascular - metabolism (2) 2
enzyme activation - physiology (2) 2
erythrocytes (2) 2
genetic aspects (2) 2
growth substances - metabolism (2) 2
half-life (2) 2
health aspects (2) 2
hedgehog proteins - antagonists & inhibitors (2) 2
hedgehogs (2) 2
human homolog (2) 2
human interleukin-8 receptor (2) 2
immunology (2) 2
in-vitro (2) 2
in-vivo (2) 2
intercellular signaling peptides and proteins (2) 2
liver - pathology (2) 2
malaria (2) 2
mice, inbred c57bl - genetics (2) 2
mice, scid (2) 2
molecular sequence data (2) 2
molecular weight (2) 2
monoclonal antibodies (2) 2
nadph oxidases - blood (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 12, pp. 1164 - 1172
Journal Article
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 04/2011, Volume 17, Issue 8, pp. 2502 - 2511
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 6/2011, Volume 108, Issue 23, pp. 9589 - 9594
Journal Article
Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 13 Supplement, pp. 2739 - 2739
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 01/2015, Volume 21, Issue 1, pp. 123 - 133
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 5/2014, Volume 73, Issue 5, pp. 951 - 960
MNRP1685A is a human monoclonal antibody that blocks binding of vascular endothelial growth factor (VEGF), VEGF-B, and placental growth factor 2 to... 
Neuropilin-1 | Medicine & Public Health | Oncology | Cancer Research | Clinical trial | Solid tumors | Pharmacology/Toxicology | Bevacizumab | SAFETY | VEGF | RECEPTOR | RENAL-CELL CARCINOMA | BIOMARKERS | ONCOLOGY | PHARMACOLOGY & PHARMACY | INHIBIT | ENDOTHELIAL GROWTH-FACTOR | Neoplasms - metabolism | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Paclitaxel - pharmacokinetics | Neuropilin-1 - therapeutic use | Young Adult | Angiogenesis Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized - pharmacokinetics | Aged, 80 and over | Angiogenesis Inhibitors - therapeutic use | Adult | Female | Angiogenesis Inhibitors - adverse effects | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Paclitaxel - adverse effects | Treatment Outcome | Paclitaxel - therapeutic use | Neoplasms - drug therapy | Antibodies, Monoclonal - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Neoplasms - pathology | Neuropilin-1 - administration & dosage | Antimitotic agents | Complications and side effects | Care and treatment | Endothelial growth factors | Monoclonal antibodies | Clinical trials | Antineoplastic agents | Tumors | Index Medicus
Journal Article
Cancer Research, ISSN 0008-5472, 07/2016, Volume 76, Issue 14 Supplement, pp. 4257 - 4257
First two authors contributed equally 
Journal Article
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 2016
BCL-2 family proteins dictate survival of human multiple myeloma cells, making them attractive drug targets. Indeed, multiple myeloma cells are sensitive to... 
Life Sciences | Cancer
Journal Article
Journal Article
Stroke, ISSN 0039-2499, 1997, Volume 28, Issue 11, pp. 2252 - 2258
Background and Purpose Free radicals account for a significant proportion of the brain damage that occurs during ischemic stroke. Using mutant mice (X-CGD)... 
Cerebral ischemia | Mice | Free radicals | Reperfusion | Neutrophils | free radicals | OXYGEN RADICALS | RAT | CHRONIC GRANULOMATOUS-DISEASE | CONJUGATED SUPEROXIDE-DISMUTASE | mice | CLINICAL NEUROLOGY | CELL-DAMAGE | cerebral ischemia | CEREBRAL-ARTERY OCCLUSION | NITRIC-OXIDE | PERIPHERAL VASCULAR DISEASE | NEUTROPHIL DEPLETION | BRAIN INJURY | neutrophils | reperfusion | TRANSGENIC MICE | Index Medicus
Journal Article
The Journal of Molecular Diagnostics, ISSN 1525-1578, 11/2017, Volume 19, Issue 6, pp. 921 - 932
Circulating tumor DNA (ctDNA) has potential to serve as a biomarker for noninvasive monitoring of treatment response and disease progression. However, broad... 
BREAST-CANCER | MUTATIONS | PATHOLOGY | SOLID TUMORS | Biomarkers, Tumor - blood | Multiplex Polymerase Chain Reaction - methods | Neoplasms - blood | Neoplasms - genetics | Humans | Circulating Tumor DNA - blood | Mutation | High-Throughput Nucleotide Sequencing - methods | Neoplasms - pathology | Microfluidics - methods | Index Medicus
Journal Article